FDA Appeared To Believe Novartis Data Manipulation Issues Had Been Rectified Months Before Public Controversy

An FDA said Novartis scientists were “already aware” of the issues with the test and had run an independent analysis of corrected data the company submitted to the agency. In other pharmaceutical news, Britsol-Myers moves closer to completing its acquisition of Celgene.

from Kaiser Health News https://ift.tt/2ZnbvZh